Back to Search Start Over

Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation

Authors :
Nieuwlaat, Robby
Eurlings, Luc W.
Cleland, John G.
Cobbe, Stuart M.
Vardas, Panos E.
Capucci, Alessandro
López-Sendòn, José L.
Meeder, Joan G.
Pinto, Yigal M.
Crijns, Harry J.G.M.
ACS - Amsterdam Cardiovascular Sciences
Cardiology
Source :
Journal of the American College of Cardiology, 53(18), 1690-1698. Elsevier USA
Publication Year :
2009

Abstract

OBJECTIVES: Our aim was to identify shortcomings in the management of patients with both atrial fibrillation (AF) and heart failure (HF). BACKGROUND: AF and HF often coincide in cardiology practice, and they are known to worsen each other's prognosis, but little is known about the quality of care of this combination. METHODS: In the observational Euro Heart Survey on AF, 5,333 AF patients were enrolled in 182 centers across 35 European Society of Cardiology member countries in 2003 and 2004. A follow-up survey was performed after 1 year. RESULTS: At baseline, 1,816 patients (34%) had HF. Recommended therapy for HF with left ventricular systolic dysfunction (LVSD) with a beta-blocker and either an angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor blocker was prescribed in 40% of HF patients, while 29% received the recommended drug therapy for both LVSD-HF and AF, consisting of the combination of a beta-blocker, either ACEI or angiotensin II receptor blocker, and oral anticoagulation. Rate control was insufficient with 40% of all HF patients with permanent AF having a heart rate

Details

Language :
English
ISSN :
07351097
Database :
OpenAIRE
Journal :
Journal of the American College of Cardiology, 53(18), 1690-1698. Elsevier USA
Accession number :
edsair.dedup.wf.001..a989acc0d9fddc8e31fb0df7b61ed5ae